Innocan Pharma received U.S. FDA approval for their over the counter CBD pain relief line

1626171101 maxresdefault



Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has just received FDA approval in the United States for their patent-pending CBD Relief &GO pain relief collection.

Bincovich talks about the collection and when they would like to have it in stores and online. She also discussed the latest on their research into Covid-19.

source

Leave a Reply

Your email address will not be published. Required fields are marked *